RADIANT trained on 119,782 RT cases and tested segmentation, dose and outcome prediction across sites. What I want next is clinical utility: does using it improve planning decisions, toxicity or outcomes? Accuracy alone isn't enough. #ESMO26 #radonc https://t.co/0MTMp2F6iI https://t.co/eczRhHiVI8